A collaboration between Yale School of Medicine and the Frazer Institute at the University of Queensland has led to the development of a non-small cell lung cancer (NSCLC) personalized treatment map, according to an announcement.
The map was created with artificial intelligence (AI) and spatial biology, according to lead researcher Thazin Aung, PhD. The scientists referred to it as a “Google Maps approach.” It has the ability to identify which treatments are going to be effective for a patient and which will not. This eliminates the need to test different treatments on patients and could save them money in the long run.
The researchers hope their strategy can also be used for other cancers to improve patient outcomes.
More information about this study can be found in Nature Genetics.
